Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pragmatic, Multicenter, Cluster, Cohort Randomized Controlled Treat-to-target Trial for Treatment of SIBO in SSc Pilot

NCT03588845 is registered in ClinicalTrials.gov with Canadian Scleroderma Research Group as lead sponsor.

NCT NCT03588845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03588845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pragmatic, Multicenter, Cluster, Cohort Randomized Controlled Treat-to-target Trial for Treatment of SIBO in SSc Pilot
Lead sponsor
Canadian Scleroderma Research Group
Phase
Not applicable
Overall status
Unknown status
Start date
February 15, 2019
Completion date
September 1, 2021
Enrollment
500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

small intestinal bacterial overgrowth, systemic sclerosis